London-based Peppy, which offers B2B2C health services for menopause, fertility, pregnancy, and early parenthood, raised a $45M Series B led by AlbionVC
Context & Ripple Effects
Peppy's $45M Series B extends a London run of health-tech rounds that keeps getting bigger: Palta's $100M Series B for health and wellness apps set the scale in 2021, and Flo Health later pushed fertility apps into unicorn territory with its $200M+ Series C from General Atlantic at a $1B+ valuation. What distinguishes Peppy is distribution — it sells through employers and health systems (B2B2C) rather than direct to consumers, covering menopause, fertility, pregnancy, and early parenthood in one package.
The raise also lands in a cluster: Birdie's $30M Series B for in-home care tools and the wider London funding streak show investors treating the city as the European center of gravity for digital health, consistent with Dealroom's finding that London has reclaimed the top spot among European tech hubs.
First-order effects
- Peppy gets capital to deepen its employer and health-system channel across all four life stages — menopause, fertility, pregnancy, and early parenthood — with AlbionVC now its lead backer.
- Employers buying family-forming and menopause benefits gain a single-vendor alternative to stitching together point solutions per life stage.
Second-order effects
- Flo Health's consumer subscription model and Peppy's employer-funded model are now competing routes to the same fertility and women's-health users, pushing both to prove which channel acquires and retains members more cheaply.
- Rival benefits platforms and insurers face pressure to bundle menopause and fertility support into standard workplace packages, or cede that line item to specialists like Peppy.
Third-order effects
- If the B2B2C pattern holds, women's and family health shifts from consumer-paid apps to an employer-benefits category, with London's cluster — Palta, Flo, Birdie, Peppy — anchoring the supply side for European employers.
- Sustained mega-rounds at Flo's scale could pull US benefits providers and insurers further into the European employer market, raising the bar for Series B-stage specialists to differentiate on breadth of life-stage coverage.
The trend: Women's and family health is being financed as an employer-funded benefits category rather than consumer apps, with London's digital-health cluster setting Europe's pace.